Electromed Inc (ELMD):企業の財務・戦略的SWOT分析

◆英語タイトル:Electromed Inc (ELMD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME1547FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥85,200見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥127,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Electromed Inc (Electromed) is a medical device company that designs, manufactures and markets respiratory care products using airway clearance technologies. The company offers smartvest airway clearance system used through in-home and in-patient therapies for respiratory treatments. It offers prescription drugs, coughing techniques, chest physical therapy, and cough-assist accessories. Electromed provides compromised airway clearance, high-frequency chest wall oscillation, prescription and reimbursement, and prescription forms. Its high-frequency chest wall oscillation device is used for the treatment of cystic fibrosis, chronic lung issues, bronchiectasis, and neuromuscular conditions. The company’s airway clearance accessories and devices include positive expiratory pressure, oscillatory pep and mechanical cough-assist device. It provides its products to the healthcare market. The company has its presence through its office located in Simi Valley, California, the US. Electromed is headquartered in New Prague, Minnesota, the US.

Electromed Inc Key Recent Developments

Mar 04,2021: Electromed, Inc. to Participate in the Sidoti Spring 2021 Virtual Investor Conference
Feb 10,2021: Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q2 2021 Results – Earnings Call Transcript
Feb 09,2021: Electromed, Inc. Announces Fiscal 2021 Second Quarter Financial Results
Jan 26,2021: Electromed, Inc. Schedules its Second Quarter Fiscal 2021 Financial Results Conference Call for February 9, 2021 at 5:00 p.m. ET
Nov 10,2020: Electromed announces fiscal 2021 first quarter financial results

This comprehensive SWOT profile of Electromed Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Electromed Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Electromed Inc – Key Information
Electromed Inc – Overview
Electromed Inc – Key Employees
Electromed Inc – Key Employee Biographies
Electromed Inc – Key Operational Heads
Electromed Inc – Major Products and Services
Electromed Inc – History
Electromed Inc – Company Statement
Electromed Inc – Locations And Subsidiaries
Electromed Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Electromed Inc – Business Description
Electromed Inc – Corporate Strategy
Electromed Inc – SWOT Analysis
SWOT Analysis – Overview
Electromed Inc – Strengths
Electromed Inc – Weaknesses
Electromed Inc – Opportunities
Electromed Inc – Threats
Electromed Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Electromed Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Electromed Inc, Key Information
Electromed Inc, Key Ratios
Electromed Inc, Share Data
Electromed Inc, Major Products and Services
Electromed Inc, History
Electromed Inc, Key Employees
Electromed Inc, Key Employee Biographies
Electromed Inc, Key Operational Heads
Electromed Inc, Other Locations
Electromed Inc, Subsidiaries
Electromed Inc, Key Competitors
Electromed Inc, SWOT Analysis
Electromed Inc, Ratios based on current share price
Electromed Inc, Annual Ratios
Electromed Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Electromed Inc (ELMD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Advisory Board Company:企業の戦略的SWOT分析
    The Advisory Board Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Medical Facilities Corp (DR):企業の財務・戦略的SWOT分析
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • hVIVO Plc (HVO):製薬・医療:M&Aディール及び事業提携情報
    Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human di …
  • Sirtex Medical Ltd (SRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin micros …
  • Perseus Mining Limited:企業の戦略・SWOT・財務情報
    Perseus Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Perseus Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mayne Pharma Group Ltd (MYX):企業の財務・戦略的SWOT分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma) formerly HalcyGen Pharmaceuticals Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company offers products such as erymax capsules, kapanol capsules, doryx capsules, magnoplasm, astrix c …
  • Bioceptive Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bioceptive Inc (Bioceptive) is a medical device company that provides medical devices for a variety of gynaecological procedures. The company offers products such as intrauterine devices, intuitive IUD insertion systems and IUD inserters, among others. Its intrauterine devices offer less tra …
  • JW Pharmaceutical Corp (001060):企業の財務・戦略的SWOT分析
    Summary JW Pharmaceutical Corp (JW Pharmaceutical), a subsidiary of JW Holdings Corp is a provider of generic drugs. The company develops and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, and others. It offers multivitamins and antianemic agent …
  • Cara Therapeutics Inc (CARA):企業の財務・戦略的SWOT分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruritus. Its lead product candidate includes …
  • Transaero Inc:企業の戦略・SWOT・財務情報
    Transaero Inc - Strategy, SWOT and Corporate Finance Report Summary Transaero Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Netflix, Inc.:企業の戦略・SWOT・財務情報
    Netflix, Inc. - Strategy, SWOT and Corporate Finance Report Summary Netflix, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Demir-Halkbank (Nederland) N.V.:企業の戦略・SWOT・財務情報
    Demir-Halkbank (Nederland) N.V. - Strategy, SWOT and Corporate Finance Report Summary Demir-Halkbank (Nederland) N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析
    Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • 23andMe Inc-医療機器分野:企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …
  • TesoRx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary TesoRx Pharma LLC (TesoRx) is a pharmaceutical company that develops treatments to address unmet medical needs. The company’s product pipeline comprises TSD-001, TSD-005, TSX-011 and TSX-002. Its TSD-001is an intravesical paclitaxel for the treatment of non-muscle invasive bladder cancer. Te …
  • Fidelity National Information Services, Inc.:企業のM&A・事業提携・投資動向
    Fidelity National Information Services, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fidelity National Information Services, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • Duke Energy Carolinas LLC-エネルギー分野:企業M&A・提携分析
    Summary Duke Energy Carolinas, LLC (Duke Energy Carolinas), a subsidiary of Duke Energy Corporation, is a regulated electric utility, which generates, transmits, distributes and sells energy. The company produces power from nuclear, coal, oil and gas, hydro, and solar sources. It is subject to the r …
  • Perdana Petroleum Bhd (PERDANA):石油・ガス:M&Aディール及び事業提携情報
    Summary Perdana Petroleum Bhd (Perdana Petroleum), a subsidiary of Dayang Enterprise Holdings Bhd, is an offshore marine services provider with focus on the upstream oil and gas industry. The company’s owns and operates a fleet of vessels supporting offshore activities such as exploration, developme …
  • MEDICREA Group (ALMED):企業の財務・戦略的SWOT分析
    Summary MEDICREA Group (MEDICREA) is a medical equipment company that provides surgical solutions to neurosurgeons and orthopedic surgeons. The company designs, manufactures and distributes proprietary technologies related to patient specific spinal surgery. It offers products such as polyaxial spin …
  • Harbin Bank Co Ltd:企業の戦略・SWOT・財務分析
    Harbin Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbin Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆